JACOBS LEVY EQUITY MANAGEMENT, INC

Position in CRBU — Caribou Biosciences, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in CRBU

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$681,987

-$628,648 QoQ

Shares Held

358,941

-56.5% QoQ

Ownership

0.362%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 137 holders

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 70.54585572559279.ToString("F0")% Shared 0.ToString("F0")% None 29.454144274407213.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,898,155 across 85 Biotechnology names. CRBU ranks #57 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	214,160	$165,468,582
2	INCY	Incyte Corp	1,717,978	$161,696,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	212,204	$70,211,937
4	HALO	Halozyme Therapeutics, Inc.	789,429	$51,020,796
5	RARE	Ultragenyx Pharmaceutical Inc.	1,431,071	$29,980,937
6	EXEL	Exelixis, Inc.	425,982	$18,270,367
7	AUPH	Aurinia Pharmaceuticals Inc.	1,097,189	$16,260,340
8	ARVN	Arvinas, Inc.	1,441,521	$15,280,122

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$681,987	358,941	-56.5%	Shares	Sole	2026-05-15
2025-12-31	$1,310,635	824,299	+136.1%	Shares	Sole	2026-02-13
2025-09-30	$813,363	349,083	-63.5%	Shares	Sole	2025-11-17
2025-06-30	$1,205,794	956,980	-33.6%	Shares	Sole	2025-08-14
2025-03-31	$1,316,656	1,442,121	+19.4%	Shares	Sole	2025-05-15
2024-12-31	$1,920,829	1,208,069	+177.1%	Shares	Sole	2025-02-14
2023-06-30	$1,853,102	436,024	+1253.3%	Shares	Sole	2023-08-14
2023-03-31	$171,088	32,220	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.